Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13508364 | 1.00 | PPARD (0.56) | PPARDPPARA | |
| SCHEMBL13509516 | 0.85 | PPARD (0.60) | PPARDPPARA | |
| SCHEMBL3691720 | 0.80 | PPARD (0.53) | PPARDPPARA | |
| SCHEMBL13508254 | 0.80 | PPARD (0.53) | PPARDPPARA | |
| SCHEMBL3690248 | 0.79 | PPARD (0.54) | PPARDPPARA | |
| SCHEMBL13508349 | 0.79 | PPARD (0.54) | PPARDPPARA | |
| SCHEMBL13508360 | 0.79 | LMNA (0.50) | PPARD | |
| SCHEMBL4839977 | 0.77 | PPARD (0.73) | PPARDPPARA | |
| SCHEMBL13509393 | 0.75 | PPARD (0.55) | PPARDPPARA | |
| SCHEMBL3866654 | 0.74 | PPARD (0.68) | PPARDPPARA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7655641-B2 | Sulfonamide derivatives as PPAR modulators | ELI LILLY AND COMPANY (US) | 2010-02-02 | — | — | US | disclosed |
| EP-1597248-B1 | SULFONAMIDE DERIVATIVES AS PPAR MODULATORS | LILLY CO ELI (US) | 2007-12-26 | — | — | EP | disclosed |
| US-20060217433-A1 | Sulfonamide derivatives as ppar modulators | ELI LILLY AND COMPANY (US) | 2006-09-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060217433-A1 | Sulfonamide derivatives as ppar modulators | PPARD, PPARA, PPARG | PPARD 1/4885PPARA 2/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.